BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16003293)

  • 1. Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans.
    Riksen NP; Oyen WJ; Ramakers BP; Van den Broek PH; Engbersen R; Boerman OC; Smits P; Rongen GA
    Clin Pharmacol Ther; 2005 Jul; 78(1):52-9. PubMed ID: 16003293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
    Rongen GA; Oyen WJ; Ramakers BP; Riksen NP; Boerman OC; Steinmetz N; Smits P
    Circulation; 2005 Jan; 111(2):173-8. PubMed ID: 15623546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection.
    Meijer P; Oyen WJ; Dekker D; van den Broek PH; Wouters CW; Boerman OC; Scheffer GJ; Smits P; Rongen GA
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):963-8. PubMed ID: 19359665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine prevents protection in two human models of ischemic preconditioning.
    Riksen NP; Zhou Z; Oyen WJ; Jaspers R; Ramakers BP; Brouwer RM; Boerman OC; Steinmetz N; Smits P; Rongen GA
    J Am Coll Cardiol; 2006 Aug; 48(4):700-7. PubMed ID: 16904537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II type 1 receptor blockade does not enhance apoptotic cell death during ischemia and reperfusion in humans in vivo.
    Meijer P; Wouters CW; Oyen WJ; Boerman OC; Scheffer GJ; Smits P; Rongen GA
    J Cardiovasc Pharmacol; 2011 Jun; 57(6):702-6. PubMed ID: 21423028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study.
    Engbersen R; Riksen NP; Mol MJ; Bravenboer B; Boerman OC; Meijer P; Oyen WJ; Tack C; Rongen GA; Smits P
    Cardiovasc Diabetol; 2012 Oct; 11():124. PubMed ID: 23051145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin tolerance does not limit mild ischemia-reperfusion injury in humans in vivo.
    Draisma A; de Goeij M; Wouters CW; Riksen NP; Oyen WJ; Rongen GA; Boerman OC; van Deuren M; van der Hoeven JG; Pickkers P
    Innate Immun; 2009 Dec; 15(6):360-7. PubMed ID: 19710089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effects of erythropoietin in rats subjected to ischemia-reperfusion injury: assessment of infarct size with 99mTc-annexin V.
    Doue T; Ohtsuki K; Ogawa K; Ueda M; Azuma A; Saji H; Strauss HW; Matsubara H
    J Nucl Med; 2008 Oct; 49(10):1694-700. PubMed ID: 18794258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene.
    Riksen NP; Franke B; Oyen WJ; Borm GF; van den Broek P; Boerman OC; Smits P; Rongen GA
    Eur Heart J; 2007 May; 28(9):1085-91. PubMed ID: 17376785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of nucleoside transport is required for delivery of intraarterial adenosine into the interstitium: relevance to therapeutic preconditioning in humans.
    Gamboa A; Ertl AC; Costa F; Farley G; Manier ML; Hachey DL; Diedrich A; Biaggioni I
    Circulation; 2003 Nov; 108(21):2631-5. PubMed ID: 14623808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ischemic preconditioning protocols on skeletal muscle ischemia-reperfusion injury.
    Kocman EA; Ozatik O; Sahin A; Guney T; Kose AA; Dag I; Alatas O; Cetin C
    J Surg Res; 2015 Feb; 193(2):942-52. PubMed ID: 25438960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin does not affect ischaemia-induced phosphatidylserine exposition in humans in-vivo.
    Wouters CW; Meijer P; Janssen CI; Frederix GW; Oyen WJ; Boerman OC; Smits P; Rongen GA
    J Atheroscler Thromb; 2012; 19(3):285-91. PubMed ID: 22146238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postconditioning protects against endothelial ischemia-reperfusion injury in the human forearm.
    Loukogeorgakis SP; Panagiotidou AT; Yellon DM; Deanfield JE; MacAllister RJ
    Circulation; 2006 Feb; 113(7):1015-9. PubMed ID: 16476844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system.
    Loukogeorgakis SP; Panagiotidou AT; Broadhead MW; Donald A; Deanfield JE; MacAllister RJ
    J Am Coll Cardiol; 2005 Aug; 46(3):450-6. PubMed ID: 16053957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium 99m pyrophosphate quantitation of skeletal muscle ischemia and reperfusion injury.
    Blebea J; Kerr JC; Franco CD; Padberg FT; Hobson RW
    J Vasc Surg; 1988 Aug; 8(2):117-24. PubMed ID: 2840521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the protective effect of dipyridamole and acetylsalicylic acid on long-term histologic damage in a rat model of testicular ischemia-reperfusion injury.
    Karagüzel E; Kutlu Ö; Yuluğ E; Mungan S; Kazaz İO; Tok DS; Özgür GK
    J Pediatr Surg; 2012 Sep; 47(9):1716-23. PubMed ID: 22974612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipyridamole protects the liver against warm ischemia and reperfusion injury.
    Taniguchi M; Magata S; Suzuki T; Shimamura T; Jin MB; Iida J; Furukawa H; Todo S
    J Am Coll Surg; 2004 May; 198(5):758-69. PubMed ID: 15110810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regular dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury: is it time to revisit PARIS?
    Figueredo VM; Okusa C; Kaneda K; Inamura Y; Miyamae M
    Int J Cardiol; 2014 Oct; 176(3):822-7. PubMed ID: 25156855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment.
    Taki J; Higuchi T; Kawashima A; Fukuoka M; Kayano D; Tait JF; Matsunari I; Nakajima K; Kinuya S; Strauss HW
    J Nucl Med; 2007 Aug; 48(8):1301-7. PubMed ID: 17631551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of preconditioning and adenosine pretreatment in experimental skeletal muscle reperfusion injury.
    Papanastasiou S; Estdale SE; Homer-Vanniasinkam S; Mathie RT
    Br J Surg; 1999 Jul; 86(7):916-22. PubMed ID: 10417565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.